Tri Huynh1, Karla Ali2, Shraddha Vyas2, Kaleena Dezsi2, Destiny Strickland2, Toni Basinski2, Dung-Tsa Chen3, Kun Jiang4, Barbara Centeno4, Mokenge Malafa5, Jason B Klapman5, Pamela J Hodul5, Daniel Jeong6, Jennifer B Permuth7. 1. College of Medicine, University of Florida, Gainesville, FL, USA. 2. Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. 3. Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA. 4. Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA. 5. Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA. 6. Department of Diagnostic Radiology, Moffitt Cancer Center, Tampa, FL, USA. 7. Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: jenny.permuth@moffitt.org.
Abstract
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMNs) are pre-malignant pancreatic cysts detected by imaging. Cyst size is one of many features evaluated on computed tomography (CT), magnetic resonance imaging (MRI), or endoscopic ultrasonography (EUS) to help guide IPMN management. Our objective was to determine which imaging modality best predicts pathological cyst size. METHODS: We analyzed records for 57 IPMN cases surgically treated at Moffitt Cancer Center from 2008 to 2016 for whom pre-operative CT, MRI, and EUS IPMN cyst size and post-operative pathological cyst size values were available. Long axis cyst diameter measurements were compared to each other and corresponding pathological cyst measurements using within-subjects ANOVA, Bland-Altman analysis, and linear regression. Consensus measurements were also performed on CT and MRI images. RESULTS: Cyst size measured via CT and MRI overestimated pathological size by 0.33 cm and 0.27 cm, respectively, whereas EUS underestimated pathological size by 0.05 cm and had the narrowest 95% limit of agreement (LOA). Among pathologically-confirmed cysts <3 cm, MRI overestimated pathological size by 0.30 cm (P = 0.049) and had the widest LOA, followed by EUS and CT. Among cysts ≥3 cm, EUS underestimated pathological size by 0.35 cm (P = 0.059) and MRI and CT overestimated pathological size by 0.23 cm and 0.51 cm, respectively. CONCLUSIONS: In this small retrospective study, EUS cyst size measurements correlated best with pathologic specimens compared to CT and MRI, especially for cysts < 3 cm. Larger prospective studies are needed to determine which imaging modalities are best to risk-stratify IPMNs and guide surgical versus. Non-surgical management.
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMNs) are pre-malignant pancreatic cysts detected by imaging. Cyst size is one of many features evaluated on computed tomography (CT), magnetic resonance imaging (MRI), or endoscopic ultrasonography (EUS) to help guide IPMN management. Our objective was to determine which imaging modality best predicts pathological cyst size. METHODS: We analyzed records for 57 IPMN cases surgically treated at Moffitt Cancer Center from 2008 to 2016 for whom pre-operative CT, MRI, and EUS IPMN cyst size and post-operative pathological cyst size values were available. Long axis cyst diameter measurements were compared to each other and corresponding pathological cyst measurements using within-subjects ANOVA, Bland-Altman analysis, and linear regression. Consensus measurements were also performed on CT and MRI images. RESULTS: Cyst size measured via CT and MRI overestimated pathological size by 0.33 cm and 0.27 cm, respectively, whereas EUS underestimated pathological size by 0.05 cm and had the narrowest 95% limit of agreement (LOA). Among pathologically-confirmed cysts <3 cm, MRI overestimated pathological size by 0.30 cm (P = 0.049) and had the widest LOA, followed by EUS and CT. Among cysts ≥3 cm, EUS underestimated pathological size by 0.35 cm (P = 0.059) and MRI and CT overestimated pathological size by 0.23 cm and 0.51 cm, respectively. CONCLUSIONS: In this small retrospective study, EUS cyst size measurements correlated best with pathologic specimens compared to CT and MRI, especially for cysts < 3 cm. Larger prospective studies are needed to determine which imaging modalities are best to risk-stratify IPMNs and guide surgical versus. Non-surgical management.
Authors: Masao Tanaka; Carlos Fernández-Del Castillo; Terumi Kamisawa; Jin Young Jang; Philippe Levy; Takao Ohtsuka; Roberto Salvia; Yasuhiro Shimizu; Minoru Tada; Christopher L Wolfgang Journal: Pancreatology Date: 2017-07-13 Impact factor: 3.996
Authors: Nils D Arvold; Andrzej Niemierko; Harvey J Mamon; Carlos Fernandez-del Castillo; Theodore S Hong Journal: Int J Radiat Oncol Biol Phys Date: 2010-08-12 Impact factor: 7.038
Authors: Mee Joo Kang; Jin-Young Jang; Soo Jin Kim; Kyoung Bun Lee; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon; Sun-Whe Kim Journal: Clin Gastroenterol Hepatol Date: 2010-09-17 Impact factor: 11.382
Authors: Sébastien Gaujoux; Murray F Brennan; Mithat Gonen; Michael I D'Angelica; Ronald DeMatteo; Yuman Fong; Mark Schattner; Christopher DiMaio; Maria Janakos; William R Jarnagin; Peter J Allen Journal: J Am Coll Surg Date: 2011-04 Impact factor: 6.113
Authors: Nandhini Srinivasan; Jin-Yao Teo; Yung-Ka Chin; Tiffany Hennedige; Damien M Tan; Albert S Low; Choon Hua Thng; Brian K P Goh Journal: HPB (Oxford) Date: 2018-02-24 Impact factor: 3.647
Authors: Thu Tran; Chandru P Sundaram; Clinton D Bahler; John N Eble; David J Grignon; M Francesca Monn; Novae B Simper; Liang Cheng Journal: J Cancer Date: 2015-07-02 Impact factor: 4.207
Authors: Andrew Jay Bowen; Serban San-Marina; Danielle Hunter; Stephen Voss; Kathleen Bartemes; Slobodan Macura; Ryan Meloche; Andrew Mearns Spragg; Christine Lohse; Michael S Oldenburg; Dale C Ekbom Journal: Laryngoscope Investig Otolaryngol Date: 2022-02-02